Octreotide Treatment of Chemotherapy-induced Diarrhoea

European Journal of Cancer

Volumn 32, Issue 1, 1996, Pages 182-183

  Ginopoulos, P ^a,c   Papagiannis, Th ^a   Safridi, Ch ^a   Karvelas, F ^b   Spyropoulos, K ^a   Papadas, Th ^a   Gogos, Ch ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b UNIVERSITY GENERAL HOSPITAL OF PATRAS   (Greece)

^c NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON; CISPLATIN; DOXORUBICIN; FLUOROURACIL; FOLINIC ACID; MITOMYCIN C; OCTREOTIDE;

ADULT; AGED; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LETTER; MALE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; DIARRHEA; FEMALE; FLUOROURACIL; GASTROINTESTINAL AGENTS; HUMANS; MALE; MIDDLE AGED; OCTREOTIDE;

EID: 0029981391     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(95)00518-8     Document Type: Letter

References (12)

1. Grem JL, Shoemaker DD, Petrelli NJ, et al. Severe and fatal toxic effects observed in treatment with high and low dose leucovorin plus 5-Fluorouracil for colorectal carcinoma. Cancer Treat Rep 1987, 71, 1122.
2. Arbuck SG. Overview of clinical trials using 5-Fluorouracil and leucovorin for the treatment of colorectal cancer. Cancer, 1989, 63, 1036-1044.
3. Daugherty LM. Loperamide hydrochloride. Am Pharm 1990, 12, 45-48.
4. Comer J, Aspeling R, Mallegal D. A double-blind comparative evaluation of Loperamide versus diphenoxylate with atropine in acute diarrhea. Curr TherRes 1977, 21, 629-637.
5. Kennedy P, Present CA, Blaney D, Niseman C, King M, Gala K. Sandostatin (S) therapy for chemotherapy (CT) and radiotherapy (RT) related diarrhea (D) [Abst 1252]. Proc Am Soc Clin Oncol 1990, 9, 324.
6. Katz MD, Erstsd BL. Octreotide: A new somatostatin analogue. Clin Pharmacol 1989, 8, 255-301.
7. Petrelli N, Creaven P, Herrera L, Rustum Y. Tolerance and response of somatostatin analogue (SMS) Sandostatin for the treatment of chemotherapy induced diarrhea [Abstract 417]. Proc Am Soc Clin Oncol 1991, 10, 138.
8. Robinson EN, Fogel R: SMS 201-995: A somatostatin analogue and diarrhea in the acquired immune deficiency syndrome (AIDS). Ann Intern Med 1988, 109, 680-681.
9. Fuessl HS, Zoller WG, Kochen MM, et al. Treatment of secretory diarrhea in AIDS with somatostatin analogue SMS 201-995. Klin Wschr 1989, 67, 452-455.
10. Lembke B, Creutzfeld W, Schliser S, Ebert R, Shaw C, Koop I. Effect of somatostatin analogue Sandostatin (SMS 201-995) on gastrointestinal, pancreatic and biliary function and hormone release in normal men. Digestion 1987, 36, 108-124.
11. Jenkins SA, Baxter JN, Leinster SJ, Roberts R, Al Sumidaie A. Effects of subcutaneous SMS 201-995 on exocrine pancreatic secretion and function in men. Br J Surg 1986, 73, 1029-1030.
12. Cascinu S, Fedeli A, Lazi-Fedeli S, Catalano G. Octreotide versus Loperamide in the treatment of Fluorouracil-induced diarrhea: A randomized trial. J Clin Oncol 1993, 11, 148-151.